Assignee
GALAPAGOS NV
BE·64 granted patents·31 pending applications·237 citations·filing 2001–2023
Top patents by PatentIndex Score
95 records- 0195US11667633B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2021·Granted Jun 6, 2023·4 cites·4 claims
- 0294US9309244B2Compound useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2015·Granted Apr 12, 2016·14 cites·18 claims
- 0393US10708263B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2017·Granted Jul 7, 2020·5 cites·6 claims
- 0493US10328081B2Compound useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2017·Granted Jun 25, 2019·9 cites·8 claims
- 0593US9382247B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Jul 5, 2016·12 cites·2 claims
- 0693US8999979B2Compound useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2013·Granted Apr 7, 2015·15 cites·13 claims
- 0792US11000528B2Compound useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2019·Granted May 11, 2021·7 cites·10 claims
- 0892US9670204B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Jun 6, 2017·10 cites·20 claims
- 0990US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 1090US9249141B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Feb 2, 2016·9 cites·12 claims
- 1189US11072611B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2019·Granted Jul 27, 2021·2 cites·15 claims
- 1289US10125132B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2017·Granted Nov 13, 2018·6 cites·20 claims
- 1389US7915256B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Mar 29, 2011·12 cites·50 claims
- 1489US7501411B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2007·Granted Mar 10, 2009·12 cites·54 claims
- 1588US10526329B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2018·Granted Jan 7, 2020·4 cites·3 claims
- 1688US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 1788US8993590B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Mar 31, 2015·8 cites·17 claims
- 1887US10376520B2Methods for the treatment of cardiovascular disordersGALAPAGOS NV·Filed 2016·Granted Aug 13, 2019·4 cites·33 claims
- 1986US7306923B2Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseasesGALAPAGOS NV·Filed 2005·Granted Dec 11, 2007·7 cites·11 claims
- 2085US10919890B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2019·Granted Feb 16, 2021·4 cites·4 claims
- 2185US10206907B2Compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2016·Granted Feb 19, 2019·4 cites·6 claims
- 2285US8927543B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2012·Granted Jan 6, 2015·6 cites·9 claims
- 2384US9255095B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Feb 9, 2016·6 cites·15 claims
- 2482US11564923B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2018·Granted Jan 31, 2023·2 cites·19 claims
- 2582US9895347B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2016·Granted Feb 20, 2018·3 cites·6 claims
- 2681US9351955B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2015·Granted May 31, 2016·3 cites·14 claims
- 2781US7332337B2Viral vectors having tissue tropism for T-lymphocytes, B- and mast cellsGALAPAGOS NV·Filed 2001·Granted Feb 19, 2008·20 cites·16 claims
- 2880US11339166B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2018·Granted May 24, 2022·2 cites·20 claims
- 2980US9133210B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2014·Granted Sep 15, 2015·4 cites·14 claims
- 3080US7429459B2Methods for identifying a compound that inhibits the procession of amyloid-beta protein production in a mammalian cell expressing APP and overexpressing a G-protein coupled receptor in the cellGALAPAGOS NV·Filed 2005·Granted Sep 30, 2008·8 cites·11 claims
- 3179US10047083B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Aug 14, 2018·2 cites·16 claims
- 3279US8012983B2Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Sep 6, 2011·4 cites·12 claims
- 3377US2023022534A1Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2021·Application pending·0 cites
- 3474US10568867B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2018·Granted Feb 25, 2020·1 cites·13 claims
- 3574US10493158B2Pharmaceutical compositions for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Dec 3, 2019·4 cites·18 claims
- 3674US7615626B2Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblastsGALAPAGOS NV·Filed 2006·Granted Nov 10, 2009·1 cites·10 claims
- 3774US2022227751A1Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.GALAPAGOS NV·Filed 2021·Application pending·0 cites
- 3873US12472181B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2022·Granted Nov 18, 2025·0 cites·3 claims
- 3973US9440929B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Sep 13, 2016·2 cites·14 claims
- 4073US7968581B2Imidazolidine compounds as androgen receptor modulatorsGALAPAGOS NV·Filed 2009·Granted Jun 28, 2011·2 cites·57 claims
- 4171US11975008B2Pharmaceutical compositions comprising a JAK inhibitorGALAPAGOS NV·Filed 2021·Granted May 7, 2024·0 cites·12 claims
- 4270US9796719B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Oct 24, 2017·1 cites·15 claims
- 4370US7638288B2Methods for inducing differentiation of undifferentiated mammalian cells into osteoblastsGALAPAGOS NV·Filed 2006·Granted Dec 29, 2009·2 cites·5 claims
- 4469US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 4569US9708312B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists)GALAPAGOS NV·Filed 2013·Granted Jul 18, 2017·1 cites·17 claims
- 4669US9382254B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2014·Granted Jul 5, 2016·2 cites·21 claims
- 4768US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 4866US12065443B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2022·Granted Aug 20, 2024·0 cites·29 claims
- 4966US8883425B2Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblastsGALAPAGOS NV·Filed 2012·Granted Nov 11, 2014·1 cites·32 claims
- 5063US10568879B2Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2016·Granted Feb 25, 2020·1 cites·10 claims
Showing the top 50 of 95 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GALAPAGOS NV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →